, /PRNewswire/ -- Wayspring, a value-based care entity focused on substance use disorder (SUD) populations, today announced a capital raise led by CVS Health Ventures. The investment recognizes Wayspring's impactful approach to managing populations with SUD, showcasing the need for innovative care models. Existing investors including Valtruis (portfolio company of Welsh, Carson, Anderson & Stowe), HLM Venture Partners, and .
406 Ventures all participated in the funding round. , Executive Director and Partner at CVS Health Ventures, highlighted the strategic nature of the investment, "Wayspring has demonstrated an exceptional ability to execute a complex care model that profoundly impacts the lives of those with substance use disorder. We are impressed by the early results and will collaborate with Wayspring to continue addressing a critical need in healthcare.
" The capital will be used to expand the reach of the SUD Home program within current Wayspring states and into select new markets. This program integrates clinical care with a deep understanding of social determinants of health (SDOH) and aims to ensure that comprehensive, value-based care is both accessible and readily available to those who need it. The SUD Home program provides tailored, comprehensive solutions that address the unique needs of each member, significantly improving outcomes and reducing healthcare costs.
, CEO of Wayspring, expressed his gratitude and optimism regarding the partnership: "We are immensel.